Article

Thoma, A, Alomosh, R, Bond, HL, Akter-Miah, T, Al-Shanti, N, Degens, H, Pekovic-Vaughan, V and Lightfoot, AP (2024) A combination of major histocompatibility complex (MHC) I overexpression and type I interferon induce mitochondrial dysfunction in human skeletal myoblasts. Journal of Cellular Physiology. ISSN 0021-9541

Bell, G, Thoma, A, Hargreaves, IP and Lightfoot, AP (2024) The Role of Mitochondria in Statin‑Induced Myopathy. Drug Safety. ISSN 0114-5916

Thoma, A, Earl, KE, Goljanek‐Whysall, K and Lightfoot, AP (2022) Major histocompatibility complex I‐induced endoplasmic reticulum stress mediates the secretion of pro‐inflammatory muscle‐derived cytokines. Journal of Cellular and Molecular Medicine, 26 (24). pp. 6032-6041. ISSN 1582-1838

Thoma, A, Lyon, M, Al-Shanti, N, Nye, GA, Cooper, RG and Lightfoot, AP (2020) Eukarion-134 attenuates endoplasmic reticulum stress-induced mitochondrial dysfunction in human skeletal muscle cells. Antioxidants, 9 (8). pp. 1-19. ISSN 2076-3921

Parkes, JE, Thoma, A, Lightfoot, AP, Day, PJ, Chinoy, H and Lamb, JA (2020) MicroRNA and mRNA profiling in the idiopathic inflammatory myopathies. BMC Rheumatology, 4 (1). ISSN 2520-1026

Thoma, A, Akter-Miah, T, Reade, RL and Lightfoot, AP (2020) Targeting reactive oxygen species (ROS) to combat the age-related loss of muscle mass and function. Biogerontology, 21 (4). pp. 475-484. ISSN 1389-5729